E-resources
PDF-
Jensen, Lisette Okkels, MD, PhD; Maeng, Michael, MD, PhD; Kaltoft, Anne, MD, PhD; Thayssen, Per, MD, DMSci; Hansen, Hans Henrik Tilsted, MD; Bottcher, Morten, MD, PhD; Lassen, Jens Flensted, MD, PhD; Krussel, Lars Romer, MD, DMSci; Rasmussen, Klaus, MD, DMSci; Hansen, Knud Noerregaard, MD; Pedersen, Lars, MSc; Johnsen, Soeren Paaske, MD, PhD; Soerensen, Henrik Toft, MD, DMSci, PhD; Thuesen, Leif, MD, DMSci
Journal of the American College of Cardiology, 07/2007, Volume: 50, Issue: 5Journal Article
Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions Lisette Okkels Jensen, Michael Mæng, Anne Kaltoft, Per Thayssen, Hans Henrik Tilsted Hansen, Morten Bøttcher, Jens Flensted Lassen, Lars Romer Krussel, Klaus Rasmussen, Knud Nøerregaard Hansen, Lars Pedersen, Søren Paaske Johnsen, Henrik Toft Sørensen, Leif Thuesen We compared rates of stent thrombosis (ST), myocardial infarction (MI), death, and target lesion revascularization after implantation of drug-eluting stents (DES) and bare-metal stents (BMS), with population-based medical databases in Denmark. The DES were implanted in 3,548 patients, and BMS were implanted in 8,847 patients. The risk of definite ST was similar in the 2 groups. Very late definite ST (between 12 and 15 months after implantation) occurred more frequently in patients receiving DES. The MI and mortality were similar in the 2 groups. Target lesion revascularization was reduced by 43% in patients treated with DES.
